Results 91 to 100 of about 34,974 (164)

Changes in Flow Density Measured Using Optical Coherence Tomography Angiography after iStent Insertion in Combination with Phacoemulsification in Patients with Open-Angle Glaucoma

open access: yesJournal of Ophthalmology, 2018
Purpose. To evaluate changes in flow density after the implantation of a trabecular microbypass stent (iStent) in combination with cataract surgery. Methods.
Maged Alnawaiseh   +4 more
doaj   +1 more source

Efficacy and safety of ELIOS excimer laser trabeculostomy versus iStent inject as an adjunct to phacoemulsification: a retrospective comparative study

open access: yes
Background/aims Minimally invasive glaucoma surgery (MIGS) procedures are commonly combined with phacoemulsification to provide additional intraocular pressure (IOP) and/or topical medication reduction in patients
Keith R Martin   +13 more
core   +1 more source

Comparison of cumulative survival rates: iStent eyes vs. inject W eyes.

open access: yes
The cumulative survival rates at 6 and 12 months postoperatively for the iStent eyes were 83.6% and 66.0% and 84.0% and 78.4% for the inject W eyes, respectively. Log-rank test: p = 0.50.
Yoshihito Sakanishi (17904254)   +4 more
core   +1 more source

Comparison of temporal versus nasal positioning of iStent Inject W®

open access: yesJournal Français d'Ophtalmologie
The goal of the present study was to compare the effect of nasal versus temporal placement of the iStent Inject W® during phacoemulsification on intraocular pressure (IOP).Over 5 consecutive years, 389 eyes of 244 patients undergoing phacoemulsification with 2 iStent Inject W® injections in a tertiary referral center were included retrospectively.
Vermot-Desroches, V.   +11 more
openaire   +3 more sources

Preliminary outcomes of cataract surgery with iStent inject® W

open access: yes, 2023
This study was performed to investigate the preliminary outcomes and complications of patients with glaucoma who underwent cataract surgery with iStent inject® W implantation.
KITA, Yoshiyuki   +4 more
core  

Four-Year Outcomes of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication

open access: yesClinical Ophthalmology, 2020
Richard Lindstrom, 1 Steven R Sarkisian, 2 Richard Lewis, 3 John Hovanesian, 4 Lilit Voskanyan 5 1Minnesota Eye Consultants, Minneapolis, MN, USA; 2Oklahoma Eye Surgeons, PLLC, Oklahoma City, OK, USA; 3Sacramento Eye Consultants, Sacramento, CA, USA;
Lindstrom R   +4 more
doaj  

Five-Year, Private Sector Cost Comparison of iStent inject® W, Trabeculectomy, Glaucoma Medications for Primary Open-Angle Glaucoma With and Without Phacoemulsification: A Filipino Patient Perspective

open access: yesPhilippine Journal of Ophthalmology
Objective: To perform a cost comparison of the 5-year total direct medical costs of iStent inject® W vs. trabeculectomy vs. glaucoma medications for the treatment of primary open-angle glaucoma, with and without phacoemulsification, from the perspective ...
Jose Ma Martinez, MD   +6 more
doaj  

Intraindividuelle Vergleichsstudie in MICS & MIGS: Trabectome vs. iStent inject (K)

open access: yes, 2016
29.
Gonnermann, J   +5 more
openaire   +1 more source

Effect of iStent inject on unmedicated intraocular pressure in glaucoma: exploratory analysis of clinical trial data

open access: yes
Purpose The direct effect of iStent inject on intraocular pressure (IOP) in patients with glaucoma is difficult to quantify in pragmatic trials where rates of post-surgical IOP-lowering therapy differ between intervention groups.
Zhengyang Liu   +6 more
core   +1 more source

From first generation to the next: evolution and research trends in iStent technology

open access: yesFrontiers in Medicine
The iStent series constitutes a range of trabecular bypass minimally invasive glaucoma surgery (MIGS) devices, which offers intraocular pressure (IOP) reduction with favourable safety profiles, in patients with open-angle glaucoma (OAG). Having undergone
Bryan Chin Hou Ang   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy